Direct thrombin inhibitors: current status and future prospects

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.9, 1999-09, pp. : 1373-1384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclooxygenase inhibitors - current status and future prospects

By Dannhardt G. Kiefer W.

European Journal of Medicinal Chemistry, Vol. 36, Iss. 2, 2001-02 ,pp. : 109-126

Elsevier

Access to resources Recommend Favorite

Novel uses for current and future direct thrombin inhibitors: focus on ximelagatran and bivalirudin

By Kalus James S Caron Michael F

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. : 465-477

Informa Healthcare

Access to resources Recommend Favorite

Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 8, 2016-09 ,pp. : 945-955

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of HMG-CoA Reductase: Current and Future Prospects

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 11, 2009-01 ,pp. : 1272-1283

Bentham Science Publishers

Access to resources Recommend Favorite

Antistaphylococcal Vaccines and Immunoglobulins: Current Status and Future Prospects

By Deresinski Stan

Drugs, Vol. 66, Iss. 14, 2006-01 ,pp. : 1797-1806

Adis International

Access to resources Recommend Favorite